TRIO and eClinical Solutions to Power Digital Transformation in Cancer Trials
eClinical Solutions LLC has announced that Translational Research in Oncology (TRIO) has selected eClinical’s elluminate clinical data platform for its trial processes across its network of 700+ cancer centers.
The variety of digital health data now collected in clinical research have provided tremendous opportunities for scientific breakthrough. In the last decade, the volume of clinical data has grown by 183%, with over two-thirds of sponsors now using or piloting at least four different data sources in their trials. Despite significant innovation in data collection platforms and capabilities, including those for decentralized clinical trials (DCT), there has been less innovation on the process of ingesting, reviewing, organizing and analyzing these data streams. 75% of companies still rely on existing excel and SAS infrastructure to organize their data once it has been collected.
For more information, click here.
Unifying Industry to Better Understand GCP Guidance
May 7th 2025In this episode of the Applied Clinical Trials Podcast, David Nickerson, head of clinical quality management at EMD Serono; and Arlene Lee, director of product management, data quality & risk management solutions at Medidata, discuss the newest ICH E6(R3) GCP guidelines as well as how TransCelerate and ACRO have partnered to help stakeholders better acclimate to these guidelines.
Putting Collective Insights Into Action to Advance Cancer Care: Key Examples From ASCO 2025
June 27th 2025At ASCO 2025, clinical operations leaders gained critical insights into how AI tools, bispecific antibodies, and evolving treatment paradigms are reshaping trial design, endpoint selection, and patient stratification.
